But just two months later, in June, Novo Nordisk said its products would no longer be available through Hims & Hers, blasting the platform for endangering patients by failing to adhere to laws against mass compounding under the false guise of personalization, causing its stock to collapse 35% from $64.22 at market close on the last trading day to $41.98 the day of the announcement, based on historical data.
Like semaglutide, it is sold under different brand names based on its purpose: Victoza: An injectable medication approved for managing type 2 diabetes
For findings to be broadly applicable, the study population needs to reflect real-world patients in terms of age, gender, medical history, and dosing
Use the compounded tirzepatide dosage calculator to determine exact volumes based on your vial concentration and target dose
No, compounded semaglutide is not the same as Ozempic or Wegovy